La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.

Identifieur interne : 000E33 ( Ncbi/Checkpoint ); précédent : 000E32; suivant : 000E34

Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.

Auteurs : Olivier Rascol [France] ; Paolo Barone ; Madhuri Behari ; Murat Emre ; Nir Giladi ; C Warren Olanow ; Evzen Ruzicka ; Francesco Bibbiani ; David Squillacote ; Anna Patten ; Eduardo Tolosa

Source :

RBID : pubmed:22222634

English descriptors

Abstract

Perampanel is a selective and noncompetitive α-amino-3-hydroxy-5-methylisoxazole propionic acid-type glutamate receptor antagonist that improves motor symptoms in animal models of Parkinson disease (PD). The aim of this study was to assess the efficacy and tolerability of perampanel in L-dopa-treated patients with moderately severe PD and motor fluctuations using an active comparator study design.

DOI: 10.1097/WNF.0b013e318241520b
PubMed: 22222634


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22222634

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.</title>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale Clinical Investigation Center, Toulouse University Hospital and University of Toulouse, France. olivier.rascol@univ-tlse3.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale Clinical Investigation Center, Toulouse University Hospital and University of Toulouse</wicri:regionArea>
<wicri:noRegion>Toulouse University Hospital and University of Toulouse</wicri:noRegion>
<wicri:noRegion>Toulouse University Hospital and University of Toulouse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barone, Paolo" sort="Barone, Paolo" uniqKey="Barone P" first="Paolo" last="Barone">Paolo Barone</name>
</author>
<author>
<name sortKey="Behari, Madhuri" sort="Behari, Madhuri" uniqKey="Behari M" first="Madhuri" last="Behari">Madhuri Behari</name>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
</author>
<author>
<name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
<author>
<name sortKey="Ruzicka, Evzen" sort="Ruzicka, Evzen" uniqKey="Ruzicka E" first="Evzen" last="Ruzicka">Evzen Ruzicka</name>
</author>
<author>
<name sortKey="Bibbiani, Francesco" sort="Bibbiani, Francesco" uniqKey="Bibbiani F" first="Francesco" last="Bibbiani">Francesco Bibbiani</name>
</author>
<author>
<name sortKey="Squillacote, David" sort="Squillacote, David" uniqKey="Squillacote D" first="David" last="Squillacote">David Squillacote</name>
</author>
<author>
<name sortKey="Patten, Anna" sort="Patten, Anna" uniqKey="Patten A" first="Anna" last="Patten">Anna Patten</name>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="????">
<PubDate>
<MedlineDate>2012 Jan-Feb</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:22222634</idno>
<idno type="pmid">22222634</idno>
<idno type="doi">10.1097/WNF.0b013e318241520b</idno>
<idno type="wicri:Area/PubMed/Corpus">000898</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000898</idno>
<idno type="wicri:Area/PubMed/Curation">000862</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000862</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000862</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000862</idno>
<idno type="wicri:Area/Ncbi/Merge">000E33</idno>
<idno type="wicri:Area/Ncbi/Curation">000E33</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E33</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.</title>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale Clinical Investigation Center, Toulouse University Hospital and University of Toulouse, France. olivier.rascol@univ-tlse3.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale Clinical Investigation Center, Toulouse University Hospital and University of Toulouse</wicri:regionArea>
<wicri:noRegion>Toulouse University Hospital and University of Toulouse</wicri:noRegion>
<wicri:noRegion>Toulouse University Hospital and University of Toulouse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barone, Paolo" sort="Barone, Paolo" uniqKey="Barone P" first="Paolo" last="Barone">Paolo Barone</name>
</author>
<author>
<name sortKey="Behari, Madhuri" sort="Behari, Madhuri" uniqKey="Behari M" first="Madhuri" last="Behari">Madhuri Behari</name>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
</author>
<author>
<name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
<author>
<name sortKey="Ruzicka, Evzen" sort="Ruzicka, Evzen" uniqKey="Ruzicka E" first="Evzen" last="Ruzicka">Evzen Ruzicka</name>
</author>
<author>
<name sortKey="Bibbiani, Francesco" sort="Bibbiani, Francesco" uniqKey="Bibbiani F" first="Francesco" last="Bibbiani">Francesco Bibbiani</name>
</author>
<author>
<name sortKey="Squillacote, David" sort="Squillacote, David" uniqKey="Squillacote D" first="David" last="Squillacote">David Squillacote</name>
</author>
<author>
<name sortKey="Patten, Anna" sort="Patten, Anna" uniqKey="Patten A" first="Anna" last="Patten">Anna Patten</name>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
</analytic>
<series>
<title level="j">Clinical neuropharmacology</title>
<idno type="eISSN">1537-162X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Catechols (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Excitatory Amino Acid Antagonists (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nitriles (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Prospective Studies</term>
<term>Pyridones (therapeutic use)</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Catechols</term>
<term>Enzyme Inhibitors</term>
<term>Excitatory Amino Acid Antagonists</term>
<term>Nitriles</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Perampanel is a selective and noncompetitive α-amino-3-hydroxy-5-methylisoxazole propionic acid-type glutamate receptor antagonist that improves motor symptoms in animal models of Parkinson disease (PD). The aim of this study was to assess the efficacy and tolerability of perampanel in L-dopa-treated patients with moderately severe PD and motor fluctuations using an active comparator study design.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Barone, Paolo" sort="Barone, Paolo" uniqKey="Barone P" first="Paolo" last="Barone">Paolo Barone</name>
<name sortKey="Behari, Madhuri" sort="Behari, Madhuri" uniqKey="Behari M" first="Madhuri" last="Behari">Madhuri Behari</name>
<name sortKey="Bibbiani, Francesco" sort="Bibbiani, Francesco" uniqKey="Bibbiani F" first="Francesco" last="Bibbiani">Francesco Bibbiani</name>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<name sortKey="Patten, Anna" sort="Patten, Anna" uniqKey="Patten A" first="Anna" last="Patten">Anna Patten</name>
<name sortKey="Ruzicka, Evzen" sort="Ruzicka, Evzen" uniqKey="Ruzicka E" first="Evzen" last="Ruzicka">Evzen Ruzicka</name>
<name sortKey="Squillacote, David" sort="Squillacote, David" uniqKey="Squillacote D" first="David" last="Squillacote">David Squillacote</name>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</noCountry>
<country name="France">
<noRegion>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E33 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000E33 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:22222634
   |texte=   Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:22222634" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024